AND [TRUSTEE], TrusteeIndenture • November 15th, 2019 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 15th, 2019 Company Industry JurisdictionINDENTURE, dated as of [·], 20 , among EAGLE PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OFPreferred Stock Warrant Agreement • November 15th, 2019 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 15th, 2019 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [·], between EAGLE PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and [·], a [corporation] [national banking association] organized and existing under the laws of [·] and having a corporate trust office in [·], as warrant agent (the “Warrant Agent”).
AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OFCommon Stock Warrant Agreement • November 15th, 2019 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 15th, 2019 Company Industry JurisdictionTHIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [·], between EAGLE PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and [·], a [corporation] [national banking association] organized and existing under the laws of [·] and having a corporate trust office in [·], as warrant agent (the “Warrant Agent”).
AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFWarrant Agreement • November 15th, 2019 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 15th, 2019 Company Industry JurisdictionTHIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [·], between EAGLE PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and [·], a [corporation] [national banking association] organized and existing under the laws of [·] and having a corporate trust office in [·], as warrant agent (the “Warrant Agent”).